About Forskolin Pharma Private Limited
Data last updated:
Forskolin Pharma Private Limited is a private limited company based in Bengaluru, Karnataka, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 23 October 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U46497KA2018PTC117863. Its GSTIN is 29AADCF5428K1ZB (Karnataka).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Seshadri Srinivasan and Madenuru Govindaraj Sreelatha.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at No. 26/1 Dr.D V G Road Basavanagudi, Bengaluru, Karnataka, India – 560004.
As per the financials filed for FY 2024, the company reported a revenue of ₹4.4 Cr, a growth of 40% compared to the previous year. For the same year it recorded a net profit of ₹22.64 Lakh (net margin 5.1%) and EBITDA of ₹1.02 Cr (EBITDA margin 23.1%). Revenue has grown at a compounded annual rate (CAGR) of 7% over three years and 91% over five years.
As per MCA filings, the company has open charges of ₹58 Lakh on record. Court records list 9 cases involving the company, including 7 filed by the company; 1 case is pending.
For more details, the company can be reached via its website forskolinpharma.com.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressNo. 26/1 Dr.D V G Road Basavanagudi, Bengaluru, Karnataka, India – 560004
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Forskolin Pharma Private Limited
The main business activity of Forskolin Pharma is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Forskolin Pharma Private Limited FY 2024 filings available
Forskolin Pharma Private Limited reported revenue of ₹4.4 Cr (up 40% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Forskolin Pharma Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 91% over five years, including 40% growth in the latest year. EBITDA fell 6% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Forskolin Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹1.02 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹22.64 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Forskolin Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 23.1% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 5.1% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Forskolin Pharma are in the company report.
Financial statements from FY 2019
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Forskolin Pharma Private Limited
Forskolin Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Nikem Drugs Private Limited | ₹4.46 Cr (FY 2025) | •••• | •••• | -53.0% | •••• | Indore, Madhya Pradesh, India |
| Shikher Impex Private Limited | ₹4.45 Cr (FY 2025) | •••• | •••• | -3.0% | •••• | Mumbai, Maharashtra, India |
| Le - Vanza Pharma Private Limited | ₹4.42 Cr (FY 2025) | •••• | •••• | -6.0% | •••• | Chandigarh, India |
| Naveen Kamani Udyog Private Limited | ₹4.42 Cr (FY 2024) | •••• | •••• | -4.0% | •••• | Uttar Pradesh, India |
| Cutix Lifesciences Private Limited | ₹4.41 Cr (FY 2025) | •••• | •••• | 20.0% | •••• | Patna, Bihar, India |
| Forskolin Pharma Private Limited this company | ₹4.4 Cr (FY 2024) | •••• | •••• | 40.0% | •••• | Bengaluru, Karnataka, India |
| Kyana Labs Private Limited | ₹4.4 Cr (FY 2025) | •••• | •••• | 616.0% | •••• | Vadodara, Gujarat, India |
| Trio Healthcare Private Limited | ₹4.4 Cr (FY 2024) | •••• | •••• | -14.0% | •••• | Ahmedabad, Gujarat, India |
| Pureblue Automotive Solutions Private Limited | ₹4.4 Cr (FY 2025) | •••• | •••• | -23.0% | •••• | Bengaluru, Karnataka, India |
| Nvron Life Science Limited | ₹4.4 Cr (FY 2025) | •••• | •••• | 61.0% | •••• | Coimbatore, Tamil Nadu, India |
| Aan Pharma Pvt Ltd | ₹4.4 Cr (FY 2025) | •••• | •••• | -57.0% | •••• | Mahemdavad, Gujarat, India |
Peers are the five companies nearest above and the five nearest below Forskolin Pharma by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Forskolin Pharma Private Limited
Forskolin Pharma has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Seshadri Srinivasan Also directs: Praghvamsha Pharma Private Limited | Director | 23 Oct 2018 | 7 Years 11 Months | Current |
| Madenuru Govindaraj Sreelatha Also directs: Praghvamsha Pharma Private Limited | Director | 23 Oct 2018 | 7 Years 11 Months | Current |
| Gangadhar Mallappa Also directs: Audikesh Hospitals Private Limited | Additional Director | 22 Jun 2021 | 5 Years 3 Months | Current |
Charges & Borrowings of Forskolin Pharma Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Oct 2020 | Axis Bank Limited | ₹58 Lakh | Open |
Total charge records: 1 View all charges
Legal Cases of Forskolin Pharma Private Limited
Forskolin Pharma Private Limited has 9 court cases on record: 7 filed by Forskolin Pharma, 2 where it is another party. 1 case is pending and 8 are disposed. Status as checked between 01 Oct 2026 and 03 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 9 | 0 | 1 |
Cases on record (5 of 9)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, BENGALURU, Karnataka | Criminal complaint | Company is another party | Pending |
| District court, BENGALURU, Karnataka | Criminal complaint | Company is another party | Disposed |
| District court, BENGALURU, Karnataka | Criminal complaint | Filed by the company against an individual | Disposed |
| District court, BENGALURU, Karnataka | Criminal complaint | Filed by the company against an individual | Disposed |
| District court, BENGALURU, Karnataka | Criminal complaint | Filed by the company against an individual | Disposed |
Full case history
All 9 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Forskolin Pharma Private Limited
Employment history and EPFO contributions of people linked to Forskolin Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
CIN History of Forskolin Pharma Private Limited
Forskolin Pharma has one previous CIN (Corporate Identification Number): U51909KA2018PTC117863. The current CIN is U46497KA2018PTC117863, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U46497KA2018PTC117863 | Current |
| U51909KA2018PTC117863 | Previous |
Recent Activity on Forskolin Pharma Private Limited
Forskolin Pharma Private Limited has 3 board changes on record since 2018: 3 appointments. The latest: Gangadhar Mallappa was appointed as Additional Director on 22 Jun 2021.
Credit Ratings, Litigation & Regulatory Alerts for Forskolin Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Forskolin Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Forskolin Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Forskolin Pharma Private Limited
Forskolin Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AADCF5428K1ZB | Karnataka | Active | 29 Nov 2018 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Forskolin Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Forskolin Pharma Private Limited
Forskolin Pharma is an active private limited company based in Bengaluru, Karnataka, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 23 October 2018 (8+ years old) and is registered under CIN U46497KA2018PTC117863.
Forskolin Pharma reported revenue of ₹4.4 Cr for FY 2024 (up 40% YoY).
Forskolin Pharma has 3 current directors:
- Seshadri Srinivasan - Director
- Madenuru Govindaraj Sreelatha - Director
- Gangadhar Mallappa - Additional Director
Forskolin Pharma reported a net profit of ₹22.64 Lakh (net margin 5.1%) and EBITDA of ₹1.02 Cr (EBITDA margin 23.1%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Forskolin Pharma is 7% over three years and 91% over five years. In the latest year (FY 2024) revenue rose 40%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Forskolin Pharma is 29AADCF5428K1ZB, registered in Karnataka.
The CIN (Corporate Identification Number) of Forskolin Pharma is U46497KA2018PTC117863. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Forskolin Pharma has 9 court cases on record: 7 filed by the company. 1 is pending.
Forskolin Pharma was incorporated on 23 October 2018, making it 8+ years old. It is registered with the Registrar of Companies, Bangalore.
The peers of Forskolin Pharma by revenue are Nikem Drugs Private Limited, Shikher Impex Private Limited, Le - Vanza Pharma Private Limited, Naveen Kamani Udyog Private Limited, Cutix Lifesciences Private Limited and 5 more, all in the Pharma industry (Formulations).
Gangadhar Mallappa was appointed as Additional Director on 22 Jun 2021. Madenuru Govindaraj Sreelatha was appointed as Director on 23 Oct 2018. Seshadri Srinivasan was appointed as Director on 23 Oct 2018.